title: Ganciclovir for the treatment of congenital cytomegalovirus: what are the side effects?
authors.affiliation: Department of Microbiology, Infectious Diseases Unit, The Royal Children's Hospital Melbourne Infectious Diseases Unit, The Royal Children's Hospital Melbourne, Murdoch Children's Research Institute, Department of Paediatrics, The University of Melbourne Murdoch Children's Research Institute, Department of Microbiology and Infectious Diseases, Royal Women's Hospital, Department of Obstetrics & Gynaecology, The University of Melbourne Department of Microbiology, The Royal Children's Hospital Melbourne, Department of Paediatrics, The University of Melbourne, Department of Microbiology and Infectious Diseases, Royal Women's Hospital, Parkville, Australia.
authors.forename: Amanda
authors.initials: A
authors.lastname: Gwee
authors.forename: Nigel
authors.initials: N
authors.lastname: Curtis
authors.forename: Tom G
authors.initials: TG
authors.lastname: Connell
authors.forename: Suzanne
authors.initials: S
authors.lastname: Garland
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Daley
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D003586:Cytomegalovirus Infections / Q000097:blood / Q000151:congenital* / Q000188:drug therapy*; D015774:Ganciclovir / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced; D013921:Thrombocytopenia / Q000097:blood / Q000821:virology
chemical_list: D000998:Antiviral Agents; D003404:Creatinine; D015774:Ganciclovir